Certain febrile diseases are unaccompanied by infection or apparent hypersensitivity. In myocardial infarction or pulmonary embolism, for example, fever has been attributed to inflammation and/or tissue necrosis. Exogenous (microbial) pyrogens stimulate both human and animal monocytes/macrophages to produce endogenous pyrogen (EP) in vitro. To determine if plasma and cellular endogeneous mediators (EMs) of inflammation induced EP production, human mononuclear cells (M/L) were incubated for 18 hours with varying amounts of EM and the supernates assayed for EP in rabbits. Neutrophils (PMNs), which do not generate EP and yet are a feature of acute inflammation, were tested. Neither viable, phorbol myristic acetatestimulated PMNs nor sonicated PMNs, red blood cells, or M/L stimulated human monocytes to produce EP. Human C3b and C5a, which mediate phagocytosis and chemotaxis, respectively, were also inactive. Despite its chemoattractant properties, the synthetic peptide FMLP failed to induce EP release. Since Poly I:Poly C (PIC: a synthetic, double-stranded RNA) is a potent pyrogen in rabbits, we investigated PIC, as well as a native, single-stranded RNA (from E. coli) and DNA (from calf thymus). None was active in vitro, and only PIC caused fever when given to rabbits intravenously. In summary, we have been unable to find an endogenous activator of EP from human monocytes to explain fevers associated with inflammation alone.
INTRODUCTION
Fever is a characteristic sign of inflammation whether it be due to infection, tissue damage, or a hypersensitivity reaction. The pathogenesis of fever in infectious diseases has been attributed to certain microbial factors (such as LPS-endotoxin) that induce monocytes or macrophages of the host to release endogenous pyrogen/interleukin-1 (EP/IL-1). Specialized cells in the anterior hypothalamus are acted upon by EP/IL-1 to initiate the peripheral changes (decreased heat loss and increased heat production) that elevate body temperature [1] . Other exogenous pyrogens, including antigenantibody complexes or antigens and lectins (which appear to act indirectly via the release of lymphokines), are also recognized as inducers of EP production. However, the sequence of events by which inflammation causes fever, in the apparent absence of infection or allergy, remains unclear. Recently, urate crystals have been reported to release EP in vitro, suggesting one mechanism whereby an endogenous activator may cause fever in gouty inflammation [2] .
There are, however, other diseases often associated with fever such as myocardial or pulmonary infarction, thrombophlebitis, and dissecting aneurysm for which there is no known pyrogenic stimulus. Fever in these illnesses has generally been attributed to associated inflammation-a response to tissue injury that involves the coordinated release of multiple endogenous agents [8] .
In an attempt to identify the probable cause of fever in such diseases, components of the inflammatory process and associated by-products of tissue disruption were evaluated for their capacity to activate human monocytes to release EP in vitro.
METHODS General
Previously employed methods were utilized to insure that all procedures, glassware, and reagents were sterile and pyrogen-free [3] .
Pyrogen Assay
Techniques for assay of EP in trained rabbits were the same as reported previously [3] . Since rabbits become sensitized and react with fever when given foreign antigens after repeated intravenous inoculations, new groups of animals were used at weekly intervals. The fever response was expressed as the maximum temperature increase from baseline occurring within 60 minutes following injection. Significance of mean responses was calculated by the appropriate t-test.
Preparation of Cells and Serum
Human venous blood (100-200 ml) was collected from normal volunteers with heparinized (10 ,u/ml) syringes (heparin sodium injection [10, containing penicillin/streptomycin ([5,000 g/ml/5,000 ,u/ml] Gibco Laboratories, Grand Island, NY) and 1 ml of heparin (1,000 ,/ml). Leukocytes (enriched for monocytes and lymphocytes) were collected by centrifugation through Ficoll-Hypaque (Ficoll; Pharmacia Fine Chemicals, Piscataway, NJ; Hypaque sodium [50 percent]: Winthrop Laboratories, New York, NY) density gradients [4] .
Dextran (100,000-200,000 molecular weight; ICN Nutritional Biochemicals, Cleveland, OH) sedimentation with hypotonic lysis of erythrocytes (RBCs) was used to obtain neutrophils (PMNs) [5] .
Both monocyte-lymphocyte (M/L) fractions and PMNs were washed twice in MEM and the pellets resuspended in MEM with either 10 percent fetal bovine sera ([FBS] , Flow Laboratories, Inc.) or 10 percent autologous normal human sera (NHS) except for the Poly I:Poly C experiments where aliquots were incubated with MEM alone. Human blood for sera was obtained by venipuncture, allowed to clot for two hours at 370C, and centrifuged at 1,800 rpm x 15 minutes. To abolish complement activity, sera was then placed in a 560C stationary water bath for 15 minutes.
Cell counts were determined with a Coulter Particle Counter (model Zf; Coulter Electronics, Inc., Rockville, MD). Viability was .90 percent by eosin red exclusion. M/L fractions contained an average of 30 percent M, 68 percent L, and 1-2 percent PMNs. Each aliquot contained two or more doses of 3-5 x 106M with 6-10 x 106 L each in a volume of 4 ml/dose unless otherwise stated. Polymyxin B Polymyxin B (PMB) (50,000 ,/ml) was diluted in physiologic saline to 2,000 ,u/ml and added to each dose containing a non-cellular experimental activator (i.e., FMLP, PMA, nucleic acids, C5a, and C3b to prevent false positive results secondary to endotoxin [6] ). When added to either complement or FMLP, one batch of PMB regularly activated cells to produce EP. Since further tests with other batches did not confirm these findings, they have been omitted from the results.
Incubation
Aliquots of M/L suspended in MEM alone or MEM/NHS were placed in 30 ml tissue culture flasks (Falcon Labware, Div. Becton, Dickinson and Co., Oxnard, CA) and various activators/EMs added. Each experiment had a "negative" control (M/L in MEM with sera) and a "positive" control of either heat-killed staphylococci (20:1, bacteria:phagocytes) or 1 ng lipopolysaccharide (LPS) [7] . Exogenous pyrogens (staphylococci and LPS) were usually added with each EM to confirm that these M/L cultures were capable of EP release. All preparations were incubated for 18 hours at 370C in 5 percent C02; the aliquots were then centrifuged, and the supernates assayed for endogenous pyrogen (EP). Cell viability after 18 hours incubation was >85 percent. The samples were cultured for 48 hours in thioglycolate broth, and, in the rare instance of contamination, the results were discarded. Phorbol Myristic Acetate (PMA) PMA (Consolidated Midland Co., Brewster, NY) was reconstituted as 2.5 mg PMA per 1 ml of DMSO, diluted to 200 mg/ml in DMSO, and stored at -700C. Prior to use, it was prepared as 100 ng/ml sodium chloride solution. As a control, 100 ng PMA was incubated with 3.0 ± 0.3 x 106 M and 8.87 ± 1.6 x 106 L in 4 ml MEM/NHS per dose and assayed for EP-inducing activity.
Endogenous
To stimulate the respiratory pathway and release the metabolites and primary granules of PMNs, PMA was added (in dosages of 200 ng/2.5 x 107 cells) and incubated in a stationary water bath for ten minutes at 370C. To remove excess PMA, the cells were centrifuged and resuspended in fresh MEM/NHS. Hydrogen peroxide production by PMA-stimulated PMNs was measured by extinction of scopoletin fluorescence to verify that cell stimulation had occurred [8] .
Complement (C3b and C5) A mixture of purified human complement fragments (C3b and C5a) were kindly supplied by Dr. Donald Kreutzer (University of Connecticut School of Medicine, Farmington, CT). The ED50, defined as the concentration of the complement factor equivalent to one-half its maximum chemotactic response [9] , was 16.7 microliters (,gl). Three concentrations/activities were used: 36 x (600,ul). 48 x (800 ,ul), and 72 x (1, 200 ,ul) the ED50. Each complement concentration was added to 106M and 4-6 x 106 L, incubated, and assayed. [11] . Each FMLP concentration was added to 2.6 ± 0.3 M and 5.65 ± 3.0 x 106 L, incubated, and assayed.
Red Blood Cells (RBCs) As previously stated, PMNs were processed and the RBCs were removed from the remaining pellet and diluted into various concentrations (refer to Table 3 ) using sodium chloride irrigation solution in 1 ml aliquots. Disruption of RBCs was by sonication as described above. An aliquot of disrupted RBCs equivalent to 4 x i07-i x 109 whole RBCs was added to 3 x 106M, incubated, and assayed.
Mononuclear Cells (M/L) M/L were obtained by processing with FicollHypaque density gradients. Sonication was performed as described above and cell contents equivalent to 2 x 107M and 2.7 x 107 lymphocytes in 2 ml per dose were incubated with viable M/L and assayed.
Nucleic Acids 1. Poly I: Poly C-Poly L-lysine (Poly I:C), a synthetic, double-stranded RNA, was kindly supplied by Dr. John Kirkwood (Yale University, New Haven, CT). Stock Solution (Flow Lot 3, 111379 CMC 0.5 percent, Lot cc-134) contained 2 mg/ml Poly I:C and 1.5 mg/ml Poly L-lysine. The Poly I:C stock solution was diluted to a dose equivalent to 40 ,ug/ml sodium chloride solution. Each dose was added to 4 x 106M and 6.6 x 106Ly, incubated, and assayed. 2. Short-chain nucleic acids-Short-chain calf thymus DNA (1 mg/ml) and E. coli-derived RNA (10 mg/ml), kindly provided by Dr. Joan Steitz (Yale University School of Medicine, New Haven, CT), were supplied as stock solutions and diluted with physiologic sodium chloride solution to concentrations of 0.3 mg/ml RNA, 0.5 mg/ml RNA, and 0.2 mg/ml DNA. Each of these mediators was then added to make one or more doses containing 4 ml of MEM with 5.4 x 106M and 1.04 x I07 L, incubated, and assayed. 3. Long-chain nucleic acids-100 ,ug of calf thymus DNA (in 3 ml sodium chloride solution) and 100 ,ig of E. coli-derived RNA (in 2 ml sodium chloride solution) were given intravenously to determine their pyrogenicity and their capacity to induce EP production in vivo. RESULTS One aliquot (two doses) of each substance to be evaluated was incubated with one or two known activators (staph and LPS) to insure that the monocytes were not inhibited from releasing EP.' In all cases these positive controls produced a mean febrile response of 0.30C or greater.
'Three additional agents, prostoglandin El, fibronectin (plasma fibronectin) kindly supplied by Dr. Philip (Table 4) .
Long-chain RNA and DNA were also injected intravenously (one recipient each) but did not evoke any change in temperature suggesting in vivo EP production (Table 4) . DISCUSSION The inflammatory reaction has been defined as a series of multiple interlocking components. Injury of any type induces an immediate acute inflammatory response with two main effects: (a) exudation of fluid containing plasma and tissue mediators of inflammation, and (b) exudation of white blood cells, initially polymorphonuclear leukocytes and later mononuclear forms with their associated release of cell products [ 12] . Subsequently, factors in the exudate induce healing. Myocardial and pulmonary infarction, which are both associated with fever, result in tissue death and necrosis, thereby activating the inflammatory response in vivo. Many of the pathways by which infection produces inflammation and fever have been defined. However, no component of the inflammatory response itself has been implicated as an endogenous inducer of EP release and hence of fever.
As the characteristic cell present in acute inflammation, the PMN, no longer recognized as producing EP, is an obvious choice to be tested as a possible EM of EP release [13, 14] . PMNs contain cytoplasm, nucleus, and azurophilic (primary) and specific (secondary) granules and selectively release granule-associated (lysosomal) enzymes when appropriately stimulated. These lysosomal enzymes are capable of producing many of the features of the acute inflammatory response [15] . Therefore, both sonication of PMNs and PMA-induced primary granule release were utilized to produce breakdown of the PMN into its cellular and metabolic components. In our experiments with human blood cells, none of the PMN fractions obtained by sonication or induced by PMA was pyrogenic or an inducer of EP release. Although Herion et al. [16] reported that lysosomal fractions of rabbit (but not human) blood cells and rabbit exudate cells were pyrogenic, the findings in regard to rabbit cells were not confirmed in a later study by Hahn et al. [17] . Positive controls in which LPS or staphylococci were added to samples containing PMN fractions verified that stimulation of EP release from monocytes was possible. It is interesting to note that EP production by LPS but not staphylococci was reduced by about one-half in the presence of sonicated PMNs (Table 1 ). Collins and Wood have similarly shown that lysosomes and lysosomal basic proteins of leukocytes diminish in vitro the pyrogenic and lethal actions of endotoxin (LPS) [18] .
Phorbol myristic acetate (PMA) has been reported to be a potent inducer of lymphocyte-activating factor (LAF) [19] . Through the work of several investigators, it now appears that LAF and EP are similar, if not the same, molecule [20, 21] . [25] ; (2) chemotactic C5 fragments are present in synovial fluids of rheumatoid arthritis [25] ; and (3) chemotactic factors and substances enhancing phagocytosis are regularly generated in any type of inflammatory process. Although Goodman et al. have reported that C5 is an inducer of LAF production [26] , human fragments C3b and C5a failed to produce EP in the presence of PMB in our experiment. Again it is clear that the validity of EP/LAF production may require reinvestigation of earlier reports where the possibility of endotoxin (LPS) contamination has not been excluded [27] . In our work, both C5, and C3b were potent inducers of EP in vitro unless PMB was added.
The stimulation of PMN random locomotion, chemotaxis, lysosomal enzyme release, and the generation of superoxide (02-) are some of the activities of synthetic N-formylmethionyl peptides including N-formyl-methionyl-leucyl-phenyalanine (FMLP) [10, 11] . These activities are responses of phagocytic cells (both PMNs and M) to multiple stimuli and are commonly present during the inflammatory process. FMLP combines its chemotactic properties with the ability to trigger a burst of oxidative metabolism, thereby simulating the natural activities of C58. As Table 2 demonstrates, the natural chemoattractant C5, and.FMLP were incapable of provok- bResponse of rabbits to agent injected intravenously ing EP release. Thus it appears from these data that neither of these agents, despite having receptors on monocytes, is responsible for producing fever with inflammation alone.
The synthetic, double-stranded RNA, Poly I:Poly C, was reported to be a potent pyrogen in rabbits [28] . Natural DNA and RNA are nuclear contents released with cellular disruption, but they have never been investigated for their ability to produce EP. In general, the nucleotide sequence of DNA is both the source of information for the synthesis of proteins and the chemical basis of heredity. RNA functions as a template for genetic information and protein synthesis.
In 1970 Nordland et al. [28] reported that human sera (and plasma) and, to a lesser extent, calf sera had an inhibitory effect (due, presumably, to an RNAase) on the pyrogenicity of Poly I:Poly C. Therefore, all our experiments with nucleic acids were performed in MEM alone. The results (Table 4) suggest that neither synthetic nor natural nucleic acids stimulate EP release from human monocytes in vitro even in the absence of these serum inhibitors.
In a review of 24 cases of acute hemolytic anemia of various etiologies, Wallenstein and Aggeler describe 13 patients with temperatures of 380C or higher for which no cause could be found [29] . In similar fashion, Hirst et al. reviewed 505 cases of dissecting aneurysm and found fever higher than 380C in 23.6 percent of the patients and higher than 390C in 7.9 percent [30] . Despite features common to both, for example fever and red blood cell (RBC) disruption and hemolysis, the mechanisms by which acute nonimmune hemolytic anemia and dissecting aneurysms produce fever are unknown. These characteristics suggested that sonicated/disrupted RBCs might contain endogenous activators of EP release. As Table 3 demonstrates, dosages up to 1 x 109 sonicated RBCs failed to generate EP from monocytes, making it unlikely that this stimulus alone is responsible for producing fever in clinical situations where there is nonimmune hemolysis or sequestration of blood in tissues or cavities. CONCLUSION In 1979, Atkins and Bodel discussed several disease categories and the frequency with which they were associated with fever [31] Ryan and Majno [12] have defined inflammation as a response of living tissue to local injury which leads to accumulation of blood cells and fluids, a process presumably selected in evolution as a defense against infection. In those febrile diseases associated with sterile, nonallergic inflammation, the "invader" may be some cellular by-product of tissue damage which the body does not recognize as "self." Production of Ag-Ab complexes with fixation of complement may then stimulate monocytes to produce EP and hence fever. One argument against autosensitization as the mechanism of fever production in such states, however, is the rapid onset of fever that occurs, often within hours, after trauma, thrombophlebitis, or infarction.
Although the endogenous stimuli to EP production in acute sterile inflammation thus remain unidentified, physicians have long been aware that fever and inflamma-tion are closely associated [37] . Studies in ferrets [38] and, more dramatically, in poikilothermic lizards [39] indicate that fever is not only a product of inflammation, but, in turn, directs and accelerates the inflammatory response to the site of the infection (presumably by the generation of various chemotactic stimuli) and thereby limits its spread. Only now are we beginning to discover the number and diversity of interrelated phenomena that are controlled by IL-1 and that have presumably contributed to evolutionary aspects of survival [40] .
